Lemaitre Vascular (LMAT) FY2016 results: revenue $89 million, up 13.8% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $89 million for fiscal 2016, the year ended 31 December 2016, up 13.8% on the year before. Net income was $11 million, up 36.5%, and diluted earnings per share $0.55. The figures are the company's own, from the 10-K it filed with the SEC on 9 March 2017.
Revenue
$89 million
+13.8% on the year
FY2009FY2016
Operating margin
18.3%
14.7% a year earlier
FY2009FY2016
Net income
$11 million
+36.5% on the year
FY2009FY2016
Diluted EPS
$0.55
+31.0% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
89.2
78.4
71.1
+13.8%
Cost of revenue
26.2
24.2
22.7
+8.4%
Gross profit
62.9
54.2
48.4
+16.2%
Gross margin
70.6%
69.1%
68.1%
Research and development
6.1
5.5
4.7
+12.1%
Operating income
16.3
11.5
6.3
+41.9%
Operating margin
18.3%
14.7%
8.9%
Interest expense
0.0
n/a
0.0
Pre-tax income
16.2
11.4
6.3
+42.2%
Income tax
5.7
3.7
2.4
+54.2%
Effective tax rate
34.8%
32.1%
38.1%
Net income
10.6
7.8
3.9
+36.5%
Net margin
11.9%
9.9%
5.5%
Diluted EPS
$0.55
$0.42
$0.23
+31.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
16.9
11.4
5.5
+47.7%
Capital expenditure
2.8
2.3
1.2
+25.0%
Free cash flow
14.1
9.2
4.3
+53.4%
Free cash flow margin
15.8%
11.7%
6.1%
Cash from investing
-17.2
n/a
n/a
Cash from financing
-2.6
n/a
n/a
Depreciation and amortisation
3.6
3.4
3.3
+5.8%
Share-based compensation
1.7
1.4
1.3
+18.0%
Buybacks
0.3
0.3
0.2
+16.9%
Dividends paid
3.3
2.8
2.3
+16.8%
Dividend per share
$0.18
$0.16
$0.14
+12.5%
Diluted shares, weighted
19m
18m
17m
+5.1%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
87.5
77.9
68.2
+12.3%
Debt
0.0
0.0
0.0
Other liabilities
14.4
12.8
13.3
+12.5%
Total liabilities and equity
102
90.7
81.5
+12.4%
Fixed assets
8.0
7.0
6.9
+14.1%
Goodwill
23.4
17.8
17.3
+31.7%
Intangible assets
9.9
6.3
7.2
+56.2%
Cash and equivalents
24.3
27.5
18.7
-11.5%
Receivables
13.2
12.0
10.8
+10.2%
Inventory
19.6
15.2
16.7
+28.8%
Other assets
3.5
4.9
4.0
-28.4%
Total assets
102
90.7
81.5
+12.4%
10-K for the year ended 31 December 2016, filed 9 March 2017: the filing.